TCL Archive ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent. March 21, 2008
TCL Archive MSK Withdraws Form Breast Cancer Nutrition Study Over Chemotherapy Issue; Program Still “Going Well” June 21, 1985
TCL Archive Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement October 28, 2011
